Progressive multifocal leukoencephalopathy differential diagnosis

Progressive multifocal leukoencephalopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Progressive multifocal leukoencephalopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Progressive multifocal leukoencephalopathy differential diagnosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Progressive multifocal leukoencephalopathy differential diagnosis
CDC on Progressive multifocal leukoencephalopathy differential diagnosis
Progressive multifocal leukoencephalopathy differential diagnosis in the news
Blogs on Progressive multifocal leukoencephalopathy differential diagnosis
Progressive multifocal leukoencephalopathy
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Differentiating Progressive multifocal leukoencephalopathy from other Diseases

PML is similar to another demyelinating disease, multiple sclerosis, but since it destroys the cells that produce myelin (unlike MS, in which myelin itself is attacked but can be replaced), it progresses much more quickly.